<code id='2A99813DD7'></code><style id='2A99813DD7'></style>
    • <acronym id='2A99813DD7'></acronym>
      <center id='2A99813DD7'><center id='2A99813DD7'><tfoot id='2A99813DD7'></tfoot></center><abbr id='2A99813DD7'><dir id='2A99813DD7'><tfoot id='2A99813DD7'></tfoot><noframes id='2A99813DD7'>

    • <optgroup id='2A99813DD7'><strike id='2A99813DD7'><sup id='2A99813DD7'></sup></strike><code id='2A99813DD7'></code></optgroup>
        1. <b id='2A99813DD7'><label id='2A99813DD7'><select id='2A99813DD7'><dt id='2A99813DD7'><span id='2A99813DD7'></span></dt></select></label></b><u id='2A99813DD7'></u>
          <i id='2A99813DD7'><strike id='2A99813DD7'><tt id='2A99813DD7'><pre id='2A99813DD7'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:6712
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In